Edison Group Research Report
Edison has released a report on LTR Pharma, highlighting the clinical validation of SPONTAN as a fast-acting intranasal treatment for erectile dysfunction and its progression
LTR Pharma increases ownership in LevOmega to ~43% through strategic A$1m investment
LTR Pharma has announced that it has increased its ownership in LevOmega Pty Ltd from 33% to approximately 43%. Through its wholly owned subsidiary, LTR
Conversation Series | Treating Erectile Dysfunction with Melissa Hadley Barrett
In recognition of September being Sexual Health Awareness Month, we’re pleased to share the latest episode of our Conversation Series, featuring Sexologist and Nurse Practitioner
SPONTAN® achieves 100% patient satisfaction in post-prostatectomy case series
Clinical collaborator and men’s health expert Melissa Hadley Barrett from Make Hard Easy and the Restorative Health Clinic presented a case series at the Asia-Pacific
SPONTAN® Strengthens Commercial Position with 18-Month Shelf Life Achievement
LTR Pharma has announced that SPONTAN® has achieved an 18-month shelf life under International Council for Harmonisation (ICH) stability conditions – a significant milestone that
US Men’s Health Expert, Dr Andrew Sun, Joins LTR Pharma’s Scientific Advisory Board
LTR Pharma is pleased to announce the appointment of Dr Andrew Y. Sun, M.D., a fellowship-trained urologist and nationally recognised expert in male sexual and